医疗补助管理式医疗计划中儿童哮喘口服糖皮质激素处方情况
该研究基于德州儿童健康计划2011至2016年索赔数据,描述1至<18岁哮喘儿童口服糖皮质激素(OCS)配药率及相关因素。结果显示每年42.1%至44.2%的哮喘儿童至少有一次OCS配药,1至4岁儿童配药率更高且重复配药常见,多数配药儿童无其他提示哮喘控制不佳的医疗利用,提示OCS过度处方。
要点
- 每年42.1%至44.2%的哮喘儿童至少有一次OCS配药。
- 1至4岁儿童OCS配药率高于年长儿童,且重复配药最常见。
- 81%至83%的OCS配药儿童无其他提示哮喘控制不佳的医疗利用。
核心结论
- 观察到的配药模式提示哮喘诊断儿童中存在大量OCS过度处方。
研究设计与样本
- 研究提取德州儿童健康计划计算机数据库2011年1月至2016年1月间1至<18岁哮喘诊断儿童的索赔数据。
主要发现
- 2011至2015年,17.1%至21.8%的儿童有哮喘诊断。
- 每年42.1%至44.2%的哮喘儿童至少有一次OCS配药。
- 1至4岁儿童OCS配药率高于年长儿童,重复配药常见且在该年龄段最常见。
- 81%至83%的OCS配药儿童无其他提示哮喘控制不佳的医疗利用(过度β受体激动剂续配、急诊就诊或哮喘住院)。
- 初级保健提供者为 board-certified 儿科医生时OCS处方较其他类型提供者少,儿科医生间OCS处方率差异大(15%至86%)。
关键数值与推荐
- 按儿科医生OCS配药率四分位分组,哮喘急诊就诊差异极小,住院率无差异。
临床怎么用
- 儿科医生应关注哮喘儿童OCS过度处方问题,尤其对1至4岁儿童及无其他控制不佳证据者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Short courses of oral corticosteroid (OCS) medication are recommended for treatment of moderate to severe asthma exacerbations. Concern has been raised about OCS overuse. Our objective is to describe rates of OCS dispensing among children with asthma and factors associated with variation in OCS dispensing. METHODS: Claims data for children 1 to <18 years of age with an asthma diagnosis between January 2011 and January 2016 were extracted from the computerized databases of Texas Children's Health Plan. RESULTS: In the years 2011 to 2015, 17.1% to 21.8% of children had an asthma diagnosis. In each of these years 42.1% to 44.2% of these children had ≥1 OCS dispensing. OCS dispensing rates were higher for the children 1 to 4 years of age compared with older children. Repeated OCS dispensing was common, and was most common for children 1 to 4 years of age. Most children with an OCS dispensing (81%-83%) did not have other utilization suggesting poor asthma control (excessive β-agonist refills, emergency department visit, or hospitalization for asthma). OCSs were less commonly prescribed to patients whose primary care provider was a board-certified pediatrician compared with other types of primary care providers. There was large variation in OCS prescribing rates among pediatricians (15%-86%). There were minimal differences in asthma emergency department visits and no differences in hospitalization rates by the pediatrician's OCS dispensing rate quartile. CONCLUSIONS: The patterns of dispensing observed suggest substantial overprescribing of OCS for children with an asthma diagnosis.
引用
- Farber HJ, Silveira EA, Vicere DR, et al. Oral Corticosteroid Prescribing for Children With Asthma in a Medicaid Managed Care Program. Pediatrics. 2017. PMID: 28557753. doi:10.1542/peds.2016-4146
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。